A Day Up For Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) shot up at $0.91, a gain of 80.2%. On Fri, Aug 19, 2022, AGLE:NASDAQ hit a New 2-Week High of $0.91. The stock appeared on our News Catalysts scanner on Thu, Aug 18, 2022 at 06:44 PM in the 'BIOTECH' category. From Fri, Aug 05, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Apr 12, 2022 at $3.17 with a volume of 11M+.
About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Top 10 Gainers:
- GigaCloud Technology Inc (GCT:NASDAQ), 205.99%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 80.23%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 40.35%
- Lottery.com Inc. (LTRY:NASDAQ), 31.83%
- Volcon Inc. (VLCN:NASDAQ), 31.52%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 29.54%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 21.36%
- Immunovant, Inc. (IMVT:NASDAQ), 21.05%
- Foot Locker, Inc. (FL:NYSE), 20.04%